Refer China: City Orders Real-Name Registration for Chikungunya Fever Med

NEWS

City Orders Real-Name Registration for Chikungunya Fever Medication

The southern city of Foshan has required real-name registration for medication to treat chikungunya fever, while two cities in southeastern China have asked travellers returning from affected areas to monitor their health for signs of the mosquito-borne illness.

Check our latest video on China Visa and foreign-related knowledge!

Follow our channel for updates 👇

The market supervision bureau in Foshan, Guangdong province issued a public notice on Sunday asking all retail pharmacies to start real-name registration and to keep records when selling medications to treat symptoms of chikungunya, including fever, rashes and joint pain.

This practice was also used during the Covid-19 pandemic to help track potential cases that were not reported.

Chikungunya fever is a viral disease transmitted by the Aedes mosquito. It cannot be contracted through direct contact with another person. While rarely fatal, the illness can lead to debilitating symptoms lasting weeks.

Those who buy the medications are required to provide their personal information and tell pharmacies about any recent mosquito bites or chikungunya symptoms, according to the notice.

A total of 47 medicines, including children's versions, are now under focused control. This includes cold medications such as Ganmaoling, Paracetamol-Caffeine tablets, fever-reducing medicine such as Ibuprofen, anti-allergy medicine such as Loratadine tablets, and skin treatments like Calamine lotion.